Back to Search Start Over

Regional quantification of cardiac metabolism with hyperpolarized [1-13C]-pyruvate CMR evaluated in an oral glucose challenge.

Authors :
Larson, Peder E. Z.
Tang, Shuyu
Liu, Xiaoxi
Sinha, Avantika
Dwork, Nicholas
Sivalokanathan, Sanjay
Liu, Jing
Bok, Robert
Ordovas, Karen G.
Slater, James
Gordon, Jeremy W.
Abraham, M. Roselle
Source :
Journal of Cardiovascular Magnetic Resonance (Elsevier B.V. ); 12/12/2023, Vol. 25 Issue 1, p1-13, 13p
Publication Year :
2023

Abstract

Background: The heart has metabolic flexibility, which is influenced by fed/fasting states, and pathologies such as myocardial ischemia and hypertrophic cardiomyopathy (HCM). Hyperpolarized (HP) <superscript>13</superscript>C-pyruvate MRI is a promising new tool for non-invasive quantification of myocardial glycolytic and Krebs cycle flux. However, human studies of HP <superscript>13</superscript>C-MRI have yet to demonstrate regional quantification of metabolism, which is important in regional ischemia and HCM patients with asymmetric septal/apical hypertrophy. Methods: We developed and applied methods for whole-heart imaging of <superscript>13</superscript>C-pyruvate, <superscript>13</superscript>C-lactate and <superscript>13</superscript>C-bicarbonate, following intravenous administration of [1-<superscript>13</superscript>C]-pyruvate. The image acquisition used an autonomous scanning method including bolus tracking, real-time magnetic field calibrations and metabolite-specific imaging. For quantification of metabolism, we evaluated <superscript>13</superscript>C metabolite images, ratio metrics, and pharmacokinetic modeling to provide measurements of myocardial lactate dehydrogenase (LDH) and pyruvate dehydrogenase (PDH) mediated metabolic conversion in 5 healthy volunteers (fasting & 30 min following oral glucose load). Results: We demonstrate whole heart coverage for dynamic measurement of pyruvate-to-lactate conversion via LDH and pyruvate-to-bicarbonate conversion via PDH at a resolution of 6 × 6 × 21 mm<superscript>3</superscript> (<superscript>13</superscript>C-pyruvate) and 12 × 12 × 21 mm<superscript>3</superscript> (<superscript>13</superscript>C-lactate, <superscript>13</superscript>C-bicarbonate). <superscript>13</superscript>C-pyruvate and <superscript>13</superscript>C-lactate were detected simultaneously in the RV blood pool, immediately after intravenous injection, reflecting LDH activity in blood. In healthy volunteers, myocardial <superscript>13</superscript>C-pyruvate-SNR, <superscript>13</superscript>C-lactate-SNR, <superscript>13</superscript>C-bicarbonate-SNR, <superscript>13</superscript>C-lactate/pyruvate ratio, <superscript>13</superscript>C-pyruvate-to-lactate conversion rate, k<subscript>PL</subscript>, and <superscript>13</superscript>C-pyruvate-to-bicarbonate conversion rate, k<subscript>PB</subscript>, all had statistically significant increases following oral glucose challenge. k<subscript>PB</subscript>, reflecting PDH activity and pyruvate entering the Krebs Cycle, had the highest correlation with blood glucose levels and was statistically significant. Conclusions: We demonstrate first-in-human regional quantifications of cardiac metabolism by HP <superscript>13</superscript>C-pyruvate MRI that aims to reflect LDH and PDH activity. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1532429X
Volume :
25
Issue :
1
Database :
Complementary Index
Journal :
Journal of Cardiovascular Magnetic Resonance (Elsevier B.V. )
Publication Type :
Academic Journal
Accession number :
174206818
Full Text :
https://doi.org/10.1186/s12968-023-00972-7